Topiramate withdrawal
Related Articles
- SECTION 7 METABOLIC DISORDERS. // MPR - Pharmacist's Edition;Fall2014, Vol. 8 Issue 3, p131
The article offers information on several drugs for the treatment of obesity. The Belviq weight-loss medication from pharmaceutical firm Eisai Co. Ltd. should be used together with a reduced-calorie diet and weight maintenance to treat obesity. Obese patients are advised to take the Qsymia...
- Review of the pharmacologic arsenal for the war on obesity. Derbyshire, Mary Beth; Shek, Allen; Szkotak, Jonathan // Formulary;Apr2013, Vol. 48 Issue 4, p136
Obesity has become a highly prevalent chronic condition that is associated with significant morbidity and mortality. Studies have demonstrated that even as little as 5% to 10% of weight loss is associated with an improvement in cardiovascular risk factors and a reduction in the incidence of type...
- The uphill battle facing antiobesity drugs. Daubresse, M; Alexander, G C // International Journal of Obesity;Mar2015, Vol. 39 Issue 3, p377
The authors reflect on the limited adoption of antibobesity drugs in clinical practice in the U.S. despite their association with short-term weight loss. They cite several antiobesity drugs that were withdrawn from the market due to the occurrence of adverse effects including sibutramine and...
- Orlistat. // Reactions Weekly;11/10/2012, Issue 1427, p35
The article describes two cases of male patients who developed oral aphthous ulcers while undergoing orlistat therapy.
- Topiramate. // Reactions Weekly;9/22/2012, Issue 1420, p46
The article describes three case reports of anorexia in children with moderate or severe mental retardation induced by topiramate therapy for symptomatic Lennox-Gastaut syndrome.
- Topiramate. // Reactions Weekly;9/22/2012, Issue 1420, p47
The article describes the case of a 31-year-old man who experienced erectile dysfunction during topiramate therapy for the treatment of encephalitis with seizures.
- Topiramate/valproate. // Reactions Weekly;Mar2015, Vol. 1544 Issue 1, p222
The article presents case report of a man in his twenties who developed general weakness and nausea while receiving topiramate.
- Weight-Loss Aid Alert. Calechman, Steve // Natural Health;Dec2002, Vol. 32 Issue 9, p24
Reports on the warning of U.S. Food and Drug Administration against using two Chinese weight-loss supplements Chasu Jianfei Diet Capsules and Chasu Gempi due to health problems in Japan.
- Chinese slimming capsules poisoning people. // Asian Pacific Post;4/16/2009, p10
The article reveals the side effects and serious health problems caused by Chinese slimming capsules available on the Internet.